Jpmorgan Chase & CO Prestige Consumer Healthcare Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 272,255 shares of PBH stock, worth $23.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
272,255
Previous 263,722
3.24%
Holding current value
$23.1 Million
Previous $18.2 Million
8.09%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PBH
# of Institutions
338Shares Held
50.4MCall Options Held
6.3KPut Options Held
0-
Black Rock Inc. New York, NY8.28MShares$702 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$482 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.96MShares$251 Million0.05% of portfolio
-
Ariel Investments, LLC Chicago, IL2.78MShares$236 Million2.25% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$227 Million0.21% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $4.22B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...